096423394	096423394	CD	B-NP	O
|	|	NN	I-NP	O
LCH	LCH	NN	I-NP	O
|	|	NN	I-NP	O
07903896	07903896	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
217158	217158	CD	B-NP	O
|	|	CC	I-NP	O
3/24/2002	3/24/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
resolved	resolve	VBD	B-VP	O
,	,	,	O	O
r/o	r/o	NN	B-NP	O
MI	MI	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/20/2002	3/20/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/12/2002	2/12/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
DELOSANGLEL	DELOSANGLEL	NNP	B-NP	O
,	,	,	O	O
ALBERTO	ALBERTO	NNP	B-NP	O
V	V	NNP	I-NP	O
601-44-98-4	601-44-98-4	CD	I-NP	O
Verl	Verl	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/30/02	2/30/02	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
QUINCY	QUINCY	NNP	B-NP	O
,	,	,	O	O
DORSEY	DORSEY	NNP	B-NP	O
SALVADOR	SALVADOR	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

COLACE	COLACE	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRINIVIL	PRINIVIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/3/02	4/3/02	CD	B-NP	O
by	by	IN	B-PP	O
MATAKA	MATAKA	NNP	B-NP	O
,	,	,	O	O
HIRAM	HIRAM	NNP	B-NP	O
ELLIS	ELLIS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
OCEAN	OCEAN	NNP	B-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
0.65	0.65	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
QID	QID	NN	I-NP	O
PRN	PRN	NN	I-NP	O
congestion	congestion	NN	I-NP	O
MVI	MVI	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/3/02	4/3/02	CD	B-NP	O
by	by	IN	B-PP	O
CORIA	CORIA	NNP	B-NP	O
,	,	,	O	O
WARREN	WARREN	NNP	B-NP	O
DOMINICK	DOMINICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
DOVONEX	DOVONEX	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
CALCIPOTRIENE	CALCIPOTRIENE	NN	B-NP	O
0.005	0.005	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
FLOMAX	FLOMAX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TAMSULOSIN	TAMSULOSIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DETROL	DETROL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TOLTERODINE	TOLTERODINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/30/02	2/30/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
problems	problem	NNS	I-NP	O
PALMITATE	PALMITATE	NNP	I-NP	O
A	A	NNP	I-NP	O
15	15	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
unit	unit	NN	I-NP	O
unknown	unknown	JJ	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
AMARYL	AMARYL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
GLIMEPIRIDE	GLIMEPIRIDE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
MG	MG	NN	I-NP	O
qAM	qAM	NN	I-NP	O
;	;	:	O	O
4	4	CD	B-NP	O
MG	MG	NN	I-NP	O
qPM	qPM	NN	I-NP	O
PO	PO	NN	I-NP	O
2	2	CD	I-NP	O
MG	MG	NN	I-NP	O
qAM	qAM	NN	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
qPM	qPM	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
After	After	IN	B-PP	O
Appt	Appt	NN	B-NP	O
with	with	IN	B-PP	O
local	local	JJ	B-NP	O
physician	physician	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Derwitsch	Derwitsch	NNP	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
nuclear	nuclear	JJ	B-NP	O
medicine	medicine	NN	I-NP	O
,	,	,	O	O
rest-MIBI	rest-MIBI	NN	B-NP	O
7	7	CD	I-NP	O
am	am	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
resolved	resolve	VBD	B-VP	O
,	,	,	O	O
r/o	r/o	NN	B-NP	O
MI	MI	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
htn	htn	NN	I-NP	O
elev	elev	NN	I-NP	O
chol	chol	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
,	,	,	O	O
Hgb	Hgb	NN	B-NP	B-protein
A1C7	A1C7	NN	I-NP	O
.5	.5	CD	I-NP	O
1/29	1/29	CD	I-NP	O
retinitis	retinitis	NN	I-NP	O
pigmentosis	pigmentosis	NN	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vision	vision	NN	I-NP	O
h/o	h/o	NN	I-NP	O
renal	renal	JJ	I-NP	O
calculi	calculus	NNS	I-NP	O
,	,	,	O	O
4/17	4/17	CD	B-NP	O
cystoscopy	cystoscopy	NN	I-NP	O
and	and	CC	O	O
R	R	NN	B-NP	O
ureteral	ureteral	JJ	I-NP	O
stent	stent	JJ	I-NP	O
mild	mild	JJ	I-NP	O
CRI	CRI	NN	I-NP	O
psoriasis	psoriasis	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ETT-Mibi	ETT-Mibi	NNP	I-NP	O
,	,	,	O	O
ECHO	ECHO	NNP	B-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
58	58	CD	I-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
11/23	11/23	CD	I-NP	O
c/o	c/o	NN	I-NP	O
2D	2D	NN	I-NP	O
of	of	IN	B-PP	O
SS	SS	NN	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
prior	prior	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
but	but	CC	O	O
negative	negative	JJ	B-NP	O
ETT	ETT	NN	I-NP	O
1998-1999	1998-1999	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ETT-mibi	ETT-mibi	NNP	I-NP	O
1999	1999	CD	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
fixed	fix	VBN	I-NP	O
or	or	CC	I-NP	O
reversible	reversible	JJ	I-NP	O
defects	defect	NNS	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
2D	2D	NN	B-NP	O
ago	ago	RB	B-ADVP	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
SS	SS	NN	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
with	with	IN	B-PP	O
L	L	NN	B-NP	O
arm	arm	NN	I-NP	O
tingling/pain	tingling/pain	NN	I-NP	O
;	;	:	O	O
episode	episode	NN	B-NP	O
occured	occur	VBD	B-VP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
lasted	last	VBD	B-VP	O
10-15	10-15	CD	B-NP	O
'	'	SYM	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
since	since	IN	B-SBAR	O
,	,	,	O	O
almost	almost	RB	B-NP	O
all	all	DT	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
went	go	VBD	B-VP	O
up	up	RP	B-PRT	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
flights	flight	NNS	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	B-protein
last	last	JJ	B-NP	I-protein
night	night	NN	I-NP	I-protein
without	without	IN	B-PP	I-protein
difficulty	difficulty	NN	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Not	Not	RB	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
N/diaphoresis/SOB	N/diaphoresis/SOB	NN	B-NP	B-protein
.	.	.	O	O

Did	Do	VBD	B-VP	O
not	not	RB	I-VP	O
change	change	VB	I-VP	O
with	with	IN	B-PP	O
position	position	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
wife	wife	NN	I-NP	O
feels	feel	NNS	I-NP	O
that	that	IN	B-NP	O
his	his	PRP$	B-NP	O
sx	sx	NN	I-NP	O
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
complaints	complaint	NNS	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
``	``	``	O	O
heavy/labored	heavy/labored	JJ	B-NP	O
breathing	breathing	NN	I-NP	O
''	''	''	O	O
over	over	IN	B-PP	O
past	past	JJ	B-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
concurrent	concurrent	JJ	B-ADJP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
trying	try	VBG	I-VP	O
to	to	TO	I-VP	O
lose	lose	VB	I-VP	O
weight	weight	NN	B-NP	O
but	but	CC	O	O
``	``	``	O	O
lost	lose	VBD	B-VP	O
his	his	PRP$	B-NP	O
motivation	motivation	NN	I-NP	O
''	''	''	O	O
and	and	CC	O	O
went	go	VBD	B-VP	O
from	from	IN	B-PP	O
275	275	CD	B-NP	O
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
30510/18	30510/18	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
PND/orthopnea/DOE	PND/orthopnea/DOE	NNP	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
swelling	swell	VBG	I-NP	O
around	around	IN	B-PP	O
ankles	ankle	NNS	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
URI	URI	NN	B-NP	O
sx	sx	NN	I-NP	O
over	over	IN	B-PP	O
past	past	JJ	B-NP	O
week	week	NN	I-NP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
cough/stuffiness	cough/stuffiness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
f/c	f/c	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
mild	mild	JJ	I-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

URI	URI	NN	B-NP	O
sx	sx	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
before	before	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
episodes	episode	NNS	I-NP	O
began	begin	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
with	with	IN	B-PP	O
this	this	DT	B-NP	O
complaint	complaint	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
1	1	CD	B-NP	O
SLNTG	SLNTG	NN	I-NP	O
and	and	CC	I-NP	O
pressure	pressure	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
lopressor	lopressor	NN	B-NP	O
2.5	2.5	CD	I-NP	O
IV/25	IV/25	CD	I-NP	O
PO	PO	NN	I-NP	O
and	and	CC	O	O
ASA	ASA	NN	B-NP	B-protein
325	325	CD	I-NP	I-protein
.	.	.	O	O

Home	Home	NN	B-NP	O
meds	med	NNS	I-NP	O
included	include	VBD	B-VP	O
cardizem/amaryl/prinivil	cardizem/amaryl/prinivil	NN	B-NP	O
/	/	SYM	I-NP	O
lipitor/asa/flomax	lipitor/asa/flomax	NN	I-NP	O
/	/	SYM	I-NP	O
detrol	detrol	NN	I-NP	O
/	/	SYM	I-NP	O
palmitate	palmitate	NN	I-NP	B-protein
A.	A.	NN	I-NP	I-protein
No	No	NNP	I-NP	I-protein
tob	tob	NN	I-NP	I-protein
since	since	IN	B-PP	O
age	age	NN	B-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
FH	FH	NN	B-NP	O
early	early	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	B-cell_line
:	:	:	O	I-cell_line
T	T	NN	B-NP	I-cell_line
96.7	96.7	CD	I-NP	I-cell_line
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	O
139/80	139/80	CD	I-NP	O
,	,	,	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
eye	eye	NN	I-NP	O
deviated	deviate	VBN	B-VP	O
laterally	laterally	RB	B-ADVP	O
.	.	.	O	O

Periph	Periph	NN	B-NP	O
field	field	NN	I-NP	O
cut	cut	NN	I-NP	O
.	.	.	O	O

Chest	Chest	RBS	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
cm	cm	NN	I-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
I/VI	I/VI	NNP	B-NP	O
SEM	SEM	NNP	I-NP	O
RUSB	RUSB	NNP	I-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
nl	nl	NN	I-NP	O
abd	abd	NN	I-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
trace	trace	VBP	B-VP	O
pretibial	pretibial	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	RB	B-ADVP	O
.	.	.	O	O

1st	1st	LS	B-LST	O
set	set	VBP	B-VP	O
enz	enz	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Labs	Labs	NNP	B-NP	O
Cr	Cr	NNP	I-NP	O
1.4	1.4	CD	I-NP	O
-LRB-	-LRB-	SYM	O	O
baseline	baseline	NN	B-NP	O
1.3-1	1.3-1	CD	I-NP	O
.6	.6	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
CAD/ischemia	CAD/ischemia	NN	B-NP	O
:	:	:	O	O
multiple	multiple	JJ	B-NP	O
CRF	CRF	NN	I-NP	O
,	,	,	O	O
past	past	IN	B-PP	O
negative	negative	JJ	B-NP	O
ETTs	ETT	NNS	I-NP	O
,	,	,	O	O
sx	sx	NN	B-NP	O
unrelated	unrelated	JJ	B-ADJP	O
to	to	TO	B-PP	O
exertion	exertion	NN	B-NP	O
but	but	CC	I-NP	O
c/w	c/w	NN	I-NP	B-protein
angina	angina	NN	I-NP	I-protein
otherwise	otherwise	RB	B-NP	I-protein
-LRB-	-LRB-	JJ	I-NP	I-protein
pressure/L	pressure/L	NN	I-NP	I-protein
arm	arm	NN	I-NP	I-protein
paresthesia	paresthesia	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
assoc	assoc	NN	I-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
r/o	r/o	NN	B-NP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	O
enz/ekgs	enz/ekg	NNS	I-NP	O
.	.	.	O	O

Cardizem	Cardizem	NN	B-NP	O
was	be	VBD	B-VP	O
dc	dc	NN	B-NP	O
'd	'd	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
lopressor	lopressor	NN	B-NP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
atenolol	atenolol	NN	B-NP	B-protein
fo	fo	NN	I-NP	I-protein
r	r	NN	I-NP	I-protein
d/c	d/c	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
though	though	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
possible	possible	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
an	an	DT	B-NP	O
accurate	accurate	JJ	I-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
BP	BP	NN	B-NP	O
on	on	IN	B-PP	O
lopressor	lopressor	NN	B-NP	O
given	give	VBN	B-VP	O
short	short	JJ	B-NP	O
stay/nitro	stay/nitro	NN	I-NP	O
paste	paste	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NN	B-NP	B-protein

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
ACE/lipitor	ACE/lipitor	NN	B-NP	O
.	.	.	O	O

Stress	Stress	NN	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
ETT-mibi	ETT-mibi	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
separate	separate	JJ	B-ADJP	O
from	from	IN	B-PP	O
rest	rest	NN	B-NP	O
given	give	VBN	B-VP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
weight/need	weight/need	NN	I-NP	O
for	for	IN	B-PP	O
higher	high	JJR	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
marker	marker	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
walked	walk	VBD	B-VP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
'20s	'20	NNS	I-NP	O
,	,	,	O	O
reached	reach	VBD	B-VP	O
DP	DP	NN	B-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
,	,	,	I-NP	O
480	480	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
or	or	CC	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
only	only	RB	B-NP	O
small	small	JJ	I-NP	O
amt	amt	NN	I-NP	O
SOB	SOB	NN	I-NP	O
at	at	IN	B-PP	O
max	max	NN	B-NP	O
exertion	exertion	NN	I-NP	O
.	.	.	O	O

Mibi	Mibi	NNP	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid-basal	mid-basal	JJ	I-NP	B-DNA
portion	portion	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inf-lateral	inf-lateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
if	if	IN	B-SBAR	O
reversible	reversible	JJ	B-ADJP	O
would	would	MD	B-VP	O
suggest	suggest	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OM	OM	NN	I-NP	O
distribution	distribution	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
even	even	RB	B-SBAR	O
if	if	IN	I-SBAR	O
reversible	reversible	JJ	B-ADJP	O
,	,	,	O	O
was	be	VBD	B-VP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
enough	enough	JJ	I-NP	O
risk	risk	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
could	could	MD	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-NP	O
and	and	CC	I-NP	O
return	return	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
portion	portion	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
dc	dc	NN	B-NP	O
'd	'd	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
adjusted	adjusted	JJ	I-NP	O
meds	med	NNS	I-NP	O
as	as	IN	B-PP	O
above	above	JJ	B-ADJP	O
and	and	CC	O	O
will	will	MD	B-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Yao	Yao	NNP	I-NP	O
Monday	Monday	NNP	I-NP	O
to	to	TO	B-VP	O
arrange	arrange	VB	I-VP	O
BP	BP	NN	B-NP	O
check	check	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
s	s	VB	I-VP	O
how	how	WRB	B-ADVP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
inc	inc	NN	I-NP	O
SOB	SOB	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
mth	mth	NN	I-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
ECHO	ECHO	NN	B-NP	B-protein
was	be	VBD	B-VP	O
o	o	NN	B-NP	O
btained	btaine	VBN	B-VP	O
for	for	IN	B-PP	O
baseline	baseline	NN	B-NP	O
study	study	NN	I-NP	O
and	and	CC	I-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
dc	dc	NN	B-NP	B-cell_type
.	.	.	O	O

DM	DM	NN	B-NP	O
:	:	:	O	O
amaryl	amaryl	NN	B-NP	O
held	hold	VBN	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
,	,	,	O	O
ISS	ISS	NN	B-NP	O
.	.	.	O	O

microalbumin/Cr	microalbumin/Cr	NN	B-NP	O
ratio	ratio	NN	I-NP	O
was	be	VBD	B-VP	O
nl	nl	NN	B-NP	O
at	at	IN	B-PP	O
6.1	6.1	CD	B-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
51	51	CD	B-NP	O
in	in	IN	B-PP	O
11/14	11/14	CD	B-NP	O
amaryl	amaryl	NN	I-NP	O
restarted	restart	VBD	B-VP	O
for	for	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
URI	URI	NN	I-NP	O
,	,	,	O	O
resolving	resolve	VBG	B-VP	O
:	:	:	O	O
ocean	ocean	JJ	B-NP	O
spray	spray	NN	I-NP	O
GU	GU	NN	I-NP	O
:	:	:	O	O
detrol/flomax	detrol/flomax	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
return	return	VB	B-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
significant	significant	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
unrelieved	unrelieved	JJ	B-ADJP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TACKETT	TACKETT	NN	B-NP	O
,	,	,	O	O
JORDAN	JORDAN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
XT1	XT1	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/30/02	2/30/02	CD	I-NP	O
@	@	SYM	B-NP	O
05	05	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

